View Cart (0 items)
Pharmaceutical

Abbott Looks to Sell Flu Vaccine Unit

June 29, 2010
/ Print / Reprints /
| Share More
/ Text Size+
Reuters reports that Abbott Laboratories is exploring the sale of its flu vaccine unit acquired as part of its purchase of Solvay''s drugs unit. Illinois-based Abbott earlier this year completed its $6.2 billion acquisition of Belgium''s Solvay Pharmaceuticals. The unit''s flu vaccine Influvac had 162 million euros ($197 million) in sales last year, with its sales occurring outside the United States.
You must login or register in order to post a comment.

Related Events